Medmix Ltd
SIX:MEDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medmix Ltd
Research & Development
Medmix Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medmix Ltd
SIX:MEDX
|
Research & Development
-CHf19.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Research & Development
-CHf27.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Research & Development
-CHf232.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
Medacta Group SA
SIX:MOVE
|
Research & Development
-€12.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
What is Medmix Ltd's Research & Development?
Research & Development
-19.6m
CHF
Based on the financial report for Dec 31, 2025, Medmix Ltd's Research & Development amounts to -19.6m CHF.
What is Medmix Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
1%
Over the last year, the Research & Development growth was 23%. The average annual Research & Development growth rates for Medmix Ltd have been 6% over the past three years , 1% over the past five years .
